Islet Function in Gestational Diabetes

Summary

The purpose of this research is to understand how the function of the human pancreas changes during and after pregnancy.

Eligibility

Inclusion Criteria:

* Pregnant individuals with a viable singleton pregnancy who have completed second trimester gestational diabetes screening and are eligible for classification as either gestational diabetes mellitus or no gestational diabetes mellitus.
* Participants must be willing and able to provide informed consent and complete planned pregnancy and postpartum study visits.

Exclusion Criteria:

* Active systemic illness (e.g. chronic kidney disease, hypertension)
* Pre-pregnancy diabetes mellitus
* Multiple gestation, major fetal anomaly, or non-viable pregnancy on ultrasound
* Fasting glucose ≥ 100 mg/dL or HbA1c ≥ 5.7% in early pregnancy
* One abnormal value on the 3-hour 100 g oral glucose tolerance test
* Glucose at least 190 mg/dL on glucose challenge testing without subsequent 3-hour oral glucose tolerance testing
* Use of medication affecting glucose metabolism before pregnancy or in early pregnancy
* Use of glucose-lowering medication (e.g. metformin, glyburide) other than insulin to treat gestational diabetes mellitus in the current pregnancy
* History of upper gastrointestinal surgery that alters gastric emptying (e.g. bariatric surgery)
* Hemoglobin \< than 11 g/dL

Conditions2

Interventions1

Locations1 site

Find trials near these locations

Related trials

• The Role of Islet GLP-1 in the Pathogenesis of Prediabetes — Mayo Clinic
• Glucagon-like Peptide 1, Glucose Metabolism and Gastric Bypass — The University of Texas Health Science Center at San Antonio

Browse More Trials